NO20026132L - Sterkt konsentrerte stabile meloxicamlösninger - Google Patents

Sterkt konsentrerte stabile meloxicamlösninger

Info

Publication number: NO20026132L
Authority: NO; Norway
Prior art keywords: highly concentrated; concentrated stable; meloxicam solutions; stable meloxicam; solutions
Prior art date: 2000-06-20

Application number

NO20026132A

Other languages

English (en)

Other versions

NO330199B1 (no

NO20026132D0 (no

Inventor

Klaus Daneck

Martin Andreas Folger

Bernhard Hassel

Stefan Henke

Hans-Juergen Kroff

Bernd Kruss

Axel Prox

Original Assignee

Boehringer Ingelheim Vetmed

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-20

Filing date

2002-12-19

Publication date

2003-02-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7646375&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20026132(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-12-19 Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed

2002-12-19 Publication of NO20026132D0 publication Critical patent/NO20026132D0/no

2003-02-11 Publication of NO20026132L publication Critical patent/NO20026132L/no

2011-03-07 Publication of NO330199B1 publication Critical patent/NO330199B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pain & Pain Management (AREA)
Bioinformatics & Cheminformatics (AREA)
Oil, Petroleum & Natural Gas (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20026132A 2000-06-20 2002-12-19 Sterkt konsentrerte stabile vandige meloxicamlosninger samt anvendelse av slike for fremstilling av farmasoytisk preparat for behandling av sykdom NO330199B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10030345A DE10030345A1 (de)	2000-06-20	2000-06-20	Hochkonzentrierte stabile Meloxicamlösungen
PCT/EP2001/006904 WO2001097813A2 (en)	2000-06-20	2001-06-19	Highly concentrated stable meloxicam solutions

Publications (3)

Publication Number	Publication Date
NO20026132D0 NO20026132D0 (no)	2002-12-19
NO20026132L true NO20026132L (no)	2003-02-11
NO330199B1 NO330199B1 (no)	2011-03-07

Family

ID=7646375

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20026132A NO330199B1 (no)	2000-06-20	2002-12-19	Sterkt konsentrerte stabile vandige meloxicamlosninger samt anvendelse av slike for fremstilling av farmasoytisk preparat for behandling av sykdom

Country Status (31)

Country	Link
EP (1)	EP1299107B1 (no)
JP (2)	JP2003535902A (no)
KR (1)	KR100805651B1 (no)
CN (1)	CN1236774C (no)
AR (2)	AR028967A1 (no)
AT (1)	ATE297736T1 (no)
AU (2)	AU8185201A (no)
BG (1)	BG65798B1 (no)
CA (1)	CA2414063C (no)
CZ (1)	CZ302717B6 (no)
DE (2)	DE10030345A1 (no)
EA (1)	EA005765B1 (no)
EC (1)	ECSP024371A (no)
EE (1)	EE04930B1 (no)
ES (1)	ES2244643T3 (no)
HR (1)	HRP20021011B1 (no)
HU (1)	HU229184B1 (no)
IL (2)	IL153114A0 (no)
ME (1)	ME00253B (no)
MX (1)	MXPA02012732A (no)
MY (1)	MY137729A (no)
NO (1)	NO330199B1 (no)
NZ (1)	NZ523583A (no)
PT (1)	PT1299107E (no)
RS (1)	RS50142B (no)
SK (1)	SK286938B6 (no)
TW (1)	TWI250018B (no)
UA (1)	UA73584C2 (no)
UY (1)	UY26781A1 (no)
WO (1)	WO2001097813A2 (no)
ZA (1)	ZA200209989B (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020035107A1 (en)	2000-06-20	2002-03-21	Stefan Henke	Highly concentrated stable meloxicam solutions
DE10030345A1 (de) *	2000-06-20	2002-01-10	Boehringer Ingelheim Vetmed	Hochkonzentrierte stabile Meloxicamlösungen
DE10161077A1 (de)	2001-12-12	2003-06-18	Boehringer Ingelheim Vetmed	Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
EP1348436A1 (en) *	2002-03-30	2003-10-01	Boehringer Ingelheim International GmbH	Meloxicam suppositories
JP4707316B2 (ja) *	2002-10-11	2011-06-22	ロート製薬株式会社	水性液状組成物
US8992980B2 (en)	2002-10-25	2015-03-31	Boehringer Ingelheim Vetmedica Gmbh	Water-soluble meloxicam granules
DE10250081A1 (de) *	2002-10-25	2004-05-13	Boehringer Ingelheim Vetmedica Gmbh	Wasserlösliche Meloxicam Granulate
EP1568369A1 (en)	2004-02-23	2005-08-31	Boehringer Ingelheim Vetmedica Gmbh	Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004025324A1 (de) *	2004-05-19	2005-12-08	Boehringer Ingelheim Vetmedica Gmbh	Flüssige Zubereitung für die Veterinärmedizin, Verfahren zu deren Herstellung und deren Verwendung
DE102004030409A1 (de) *	2004-06-23	2006-01-26	Boehringer Ingelheim Vetmedica Gmbh	Neue Verwendung von Meloxicam in der Veterinärmedizin
CA2586288A1 (en) *	2004-12-06	2006-06-15	Janssen Pharmaceutica Nv	Oral suspension comprising meloxicam
WO2006089082A2 (en)	2005-02-17	2006-08-24	Velcera Pharmaceuticals	Transmucosal administration of drug compositions for treating and preventing disorders in animals
RU2383344C2 (ru) *	2008-01-22	2010-03-10	Закрытое Акционерное Общество "Канонфарма Продакшн"	Фармацевтический раствор мелоксикама и глицина, способ его получения и способ лечения
CN101584696A (zh) *	2008-05-21	2009-11-25	上海艾力斯医药科技有限公司	包含喹唑啉衍生物的组合物及制备方法、用途
TR200809200A1 (tr)	2008-12-01	2009-12-21	Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket�	Meloksikam içeren farmasötik formülasyonlar
EP2488145B1 (en)	2009-10-12	2024-04-24	Boehringer Ingelheim Vetmedica GmbH	Containers for compositions comprising meloxicam
SG183846A1 (en)	2010-03-03	2012-10-30	Boehringer Ingelheim Vetmed	Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en)	2010-05-05	2017-10-24	Boehringer Ingelheim Vetmedica Gmbh	Low concentration meloxicam tablets
KR101045052B1 (ko) *	2011-01-18	2011-06-28	지수광	자세교정용 발받침대
CN102908310A (zh) *	2012-11-02	2013-02-06	青岛康地恩药业股份有限公司	一种犬、猫用治疗类风湿性关节炎的美洛昔康注射液
CN104983686A (zh) *	2015-07-13	2015-10-21	胡涵	畜禽用美洛昔康可溶性粉剂及其制备方法
CN105213402B (zh) *	2015-09-30	2018-12-18	洛阳市兽药厂	一种畜禽复方恩诺沙星美洛昔康可溶性粉
EP4650374A2 (en) *	2017-05-10	2025-11-19	Axsome Therapeutics, Inc.	Pharmaceutical compositions comprising meloxicam
CA3070251A1 (en) *	2017-08-24	2019-02-28	Jiangsu Hengrui Medicine Co., Ltd.	Injectable pharmaceutical composition containing meloxicam, and preparation method therefor
KR20190107481A (ko) *	2018-03-12	2019-09-20	충북대학교 산학협력단	멜록시캄을 포함하는 구강붕해필름 제조방법 및 이에 의해 제조된 멜록시캄을 포함하는 구강붕해필름
US12059423B2 (en)	2018-05-11	2024-08-13	Nanjing Delova Biotech Co., Ltd.	Meloxicam composition, pharmaceutical preparation and preparation method and use thereof
CN112823786A (zh) *	2019-11-21	2021-05-21	北京泰德制药股份有限公司	一种含有美洛昔康的药物组合物及应用
WO2021224815A1 (en) *	2020-05-06	2021-11-11	Cadila Healthcare Limited	Stable aqueous parenteral solutions of nonsteroidal anti-inflammatory drug (nsaid)
CN115068419A (zh) *	2022-07-22	2022-09-20	潍坊恒邦兽药有限公司	兽用高浓度美洛昔康注射剂及其加工设备

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2756113A1 (de) *	1977-12-16	1979-06-21	Thomae Gmbh Dr K	Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE3217315C2 (de) *	1982-05-08	1986-05-22	Gödecke AG, 1000 Berlin	Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten
EP0173729B1 (fr) *	1984-03-14	1990-10-17	Jérôme CORBIERE	Ppocede de solubilisation de principes actifs et compositions pharmaceutiques ainsi obtenues
DE3437232A1 (de) *	1984-10-10	1986-04-17	Mack Chem Pharm	Stabilisierte injektionsloesungen von piroxicam
IT1207994B (it) *	1986-01-03	1989-06-01	Therapicon Srl	Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche.
IT1216686B (it) *	1988-04-01	1990-03-08	Chiesi Farma Spa	Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.
JPH0418022A (ja) *	1990-05-10	1992-01-22	Fujikawa Kk	ピロキシカムの安定水溶液ならびにその製造法
HU205550B (en) *	1990-11-27	1992-05-28	Egyt Gyogyszervegyeszeti Gyar	Process for producing pyroxycam solution of increased stability, free from effects damaging tussues
US5674888A (en) *	1995-06-07	1997-10-07	University Of California	Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
US5599535A (en) *	1995-06-07	1997-02-04	Regents Of The University Of California	Methods for the cyto-protection of the trabecular meshwork
ATA156496A (de) *	1996-09-03	1997-10-15	Nycomed Austria Gmbh	Pharmazeutische zusammensetzung
EP0945134A1 (de) *	1998-03-27	1999-09-29	Boehringer Ingelheim Pharma KG	Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation
KR100627620B1 (ko) *	1998-05-15	2006-09-25	와카모토 세이야꾸 가부시끼가이샤	항염증 점안제
AU1548001A (en) *	1999-11-24	2001-06-04	Wakamoto Pharmaceutical Co., Ltd.	Ophthalmic aqueous preparation
KR200182299Y1 (ko) *	1999-12-08	2000-05-15	장지일	플로스 케이스를 포함하는 플로스 홀더
DE10030345A1 (de) *	2000-06-20	2002-01-10	Boehringer Ingelheim Vetmed	Hochkonzentrierte stabile Meloxicamlösungen

2000
- 2000-06-20 DE DE10030345A patent/DE10030345A1/de not_active Ceased
2001
- 2001-06-18 TW TW090114711A patent/TWI250018B/zh not_active IP Right Cessation
- 2001-06-18 MY MYPI20012858A patent/MY137729A/en unknown
- 2001-06-19 AU AU8185201A patent/AU8185201A/xx active Pending
- 2001-06-19 PT PT01960330T patent/PT1299107E/pt unknown
- 2001-06-19 AU AU2001281852A patent/AU2001281852B2/en not_active Expired
- 2001-06-19 EE EEP200200701A patent/EE04930B1/xx unknown
- 2001-06-19 HU HU0300854A patent/HU229184B1/hu unknown
- 2001-06-19 NZ NZ523583A patent/NZ523583A/en not_active IP Right Cessation
- 2001-06-19 IL IL15311401A patent/IL153114A0/xx unknown
- 2001-06-19 WO PCT/EP2001/006904 patent/WO2001097813A2/en not_active Ceased
- 2001-06-19 HR HR20021011A patent/HRP20021011B1/xx not_active IP Right Cessation
- 2001-06-19 UA UA2003010501A patent/UA73584C2/uk unknown
- 2001-06-19 CN CNB018115608A patent/CN1236774C/zh not_active Expired - Lifetime
- 2001-06-19 RS YUP-964/02A patent/RS50142B/sr unknown
- 2001-06-19 ME MEP-2008-398A patent/ME00253B/me unknown
- 2001-06-19 UY UY26781A patent/UY26781A1/es not_active Application Discontinuation
- 2001-06-19 KR KR1020027017309A patent/KR100805651B1/ko not_active Expired - Lifetime
- 2001-06-19 ES ES01960330T patent/ES2244643T3/es not_active Expired - Lifetime
- 2001-06-19 JP JP2002503297A patent/JP2003535902A/ja not_active Abandoned
- 2001-06-19 CA CA002414063A patent/CA2414063C/en not_active Expired - Lifetime
- 2001-06-19 DE DE60111529T patent/DE60111529T2/de not_active Expired - Lifetime
- 2001-06-19 CZ CZ20024191A patent/CZ302717B6/cs not_active IP Right Cessation
- 2001-06-19 SK SK1799-2002A patent/SK286938B6/sk not_active IP Right Cessation
- 2001-06-19 EP EP01960330A patent/EP1299107B1/en not_active Expired - Lifetime
- 2001-06-19 AT AT01960330T patent/ATE297736T1/de active
- 2001-06-19 MX MXPA02012732A patent/MXPA02012732A/es active IP Right Grant
- 2001-06-19 EA EA200201254A patent/EA005765B1/ru not_active IP Right Cessation
- 2001-06-20 AR ARP010102932A patent/AR028967A1/es not_active Application Discontinuation
2002
- 2002-11-27 IL IL153114A patent/IL153114A/en active IP Right Grant
- 2002-12-03 BG BG107347A patent/BG65798B1/bg unknown
- 2002-12-05 EC EC2002004371A patent/ECSP024371A/es unknown
- 2002-12-10 ZA ZA200209989A patent/ZA200209989B/en unknown
- 2002-12-19 NO NO20026132A patent/NO330199B1/no not_active IP Right Cessation
2010
- 2010-09-21 JP JP2010210791A patent/JP5330347B2/ja not_active Expired - Lifetime
2014
- 2014-08-12 AR ARP140103015A patent/AR100293A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
UY26781A1 (es)	2002-01-31
EP1299107A2 (en)	2003-04-09
KR100805651B1 (ko)	2008-02-26
WO2001097813A2 (en)	2001-12-27
CZ302717B6 (cs)	2011-09-21
BG107347A (bg)	2003-09-30
EP1299107B1 (en)	2005-06-15
EA200201254A1 (ru)	2003-06-26
RS50142B (sr)	2009-03-25
HK1057859A1 (en)	2004-04-23
AU8185201A (en)	2002-01-02
NO330199B1 (no)	2011-03-07
IL153114A0 (en)	2003-06-24
HRP20021011A2 (en)	2005-02-28
HU229184B1 (en)	2013-09-30
JP2010280726A (ja)	2010-12-16
CA2414063C (en)	2008-06-17
DE60111529T2 (de)	2005-12-15
IL153114A (en)	2011-07-31
KR20030013447A (ko)	2003-02-14
DE60111529D1 (de)	2005-07-21
ES2244643T3 (es)	2005-12-16
HRP20021011B1 (en)	2006-02-28
CA2414063A1 (en)	2001-12-27
ECSP024371A (es)	2003-02-06
SK17992002A3 (sk)	2003-04-01
CN1437472A (zh)	2003-08-20
ZA200209989B (en)	2003-10-08
ME00253B (me)	2011-05-10
PT1299107E (pt)	2005-08-31
AU2001281852B2 (en)	2006-04-13
MXPA02012732A (es)	2004-09-10
JP2003535902A (ja)	2003-12-02
AR028967A1 (es)	2003-05-28
CZ20024191A3 (cs)	2003-04-16
EE200200701A (et)	2004-08-16
CN1236774C (zh)	2006-01-18
NO20026132D0 (no)	2002-12-19
ATE297736T1 (de)	2005-07-15
HUP0300854A2 (hu)	2003-08-28
EE04930B1 (et)	2007-12-17
JP5330347B2 (ja)	2013-10-30
PL359553A1 (en)	2004-08-23
TWI250018B (en)	2006-03-01
MY137729A (en)	2009-03-31
MEP39808A (en)	2011-02-10
AR100293A2 (es)	2016-09-28
SK286938B6 (sk)	2009-07-06
WO2001097813A3 (en)	2002-05-10
UA73584C2 (en)	2005-08-15
YU96402A (sh)	2006-01-16
BG65798B1 (bg)	2009-12-31
NZ523583A (en)	2004-09-24
EA005765B1 (ru)	2005-06-30
DE10030345A1 (de)	2002-01-10

Publication	Publication Date	Title
ATE297736T1 (de)	2005-07-15	Hochkonzentrierte stabile meloxicam-lösungen
DE50209801D1 (de)	2007-05-03	Hochkonzentrierte stabile meloxicamlösungen zur nadellosen injektion
DE60210429D1 (de)	2006-05-18	Stabile elektrolumineszenzvorrichtungen
DE60129705D1 (de)	2007-09-13	Monoalkylglycerinäther stabile zusammensetzungen
ID28865A (id)	2001-07-12	Bantalan inkontinensi absorben
NO20025115L (no)	2002-12-19	Muskarin agonister
DE50105915D1 (de)	2005-05-19	Schutzhülle
DZ3409A1 (fr)	2002-02-21	Association therapeuthique
DE50103020D1 (de)	2004-09-02	Positioniereinheit
DE60025198D1 (de)	2006-02-02	Stabile biozidale zusammensetzung
DE60140838D1 (de)	2010-02-04	Saugfähiger Gegenstand
FI20002644A0 (fi)	2000-12-01	Liitäntäalusta
NO20030917D0 (no)	2003-02-27	Anvendelse
DE60107676D1 (de)	2005-01-13	Pendel-topverteiler
DE60215601D1 (de)	2006-12-07	Stabile Zusammensetzung
DE50007505D1 (de)	2004-09-23	Positioniervorrichtung
AR028061A1 (es)	2003-04-23	2-enamino-cetonitrilos fenil-substituidos
ATE282431T1 (de)	2004-12-15	Stabile mitoxantron-lösungen
DE60144430D1 (de)	2011-05-26	Subtilase varianten
NO20031023D0 (no)	2003-03-05	Mesotrionformuleringer
DE50104548D1 (de)	2004-12-23	Lösungsvermittler
DE60143209D1 (de)	2010-11-18	Zweiport-demodulationseinrichtung
WO2002020075A3 (en)	2002-04-25	Nebulizer
DE60142057D1 (de)	2010-06-17	Dekodiervorrichtung
SI1299107T1 (sl)	2005-12-31	Visokokoncentrirane stabilne raztopine meloksikama

Legal Events

Date	Code	Title	Description
2021-07-12	MK1K	Patent expired